Why is ZBH down?
Down 9% over three years while the S&P 500 rose 81%.
- It fell 15% on Nov 5, 2025, a results day, its biggest one-day fall in three years.
The other side and the timeline, for Pro members.
ZBH's Quality Score fell 1 point on Tue, Nov 3, to 9.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 9% over three years while the S&P 500 rose 81%.
The other side and the timeline, for Pro members.
| The company | An $807M profit |
| Latest filing | 10-Q, Aug 5 |
ReportReports tomorrow, before the open. Every 3 months, a company tells everyone how much it sold and earned. It rose after 2 and fell after 2 of its last 4 reports, -5.3% on average. Past reports ›
Thu Nov 5: Annual Meeting of the American…Industry event · date confirmed.
After its last 4 reports it closed -5.3% on average, higher 2 of 4 times.
Averagefor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means
ZBH is #20 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 20 |
Sales over four quarters against a year before: ZBH +8.6%, EW +15%.
Reports Wed Nov 4, before the open (tomorrow). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 5, 2026 | +5.4% | +2.5% | +1.5% |
| Apr 28, 2026 | -5.4% | -10.6% | -10.7% |
| Feb 10, 2026 | +4.9% | +1.9% | +8.3% |
Sales grew in six of the last seven years, to $8.2B in 2025. It made a profit in six of the eight years.
3 insiders sold $1.2M across 4 filings in the last 6 months. No open-market buys on record. The newest:
18 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: ZBH is under 0.1% of SPYI, under 0.1% of IVV, and under 0.1% of SPY, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026 (SPY's as filed by IVV).
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
“The orthopedics and broader musculoskeletal care industry is highly competitive.”
ZBH scores 9 today, which Breakaway calls Average. It is #20 of 85 in Medical Devices by Quality Score, with 6 of 14 chart checks firing. Down 9% over three years while the S&P 500 rose 81%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
ZBH scores 9 today, which Breakaway calls Average (6 to 10). That is #20 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ZBH's 9.
3 insiders sold $1.2M across 4 filings in the last 6 months. No open-market buys on record. The newest is Kevin R. Thornal, Grp Pres-Global Business, who sold $529K on Sep 11. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.